Sophia Genetics SA
NASDAQ:SOPH
Intrinsic Value
The intrinsic value of one SOPH stock under the Base Case scenario is 4.58 USD. Compared to the current market price of 3.75 USD, Sophia Genetics SA is Undervalued by 18%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Sophia Genetics SA
Loading...
Fundamental Analysis

Revenue & Expenses Breakdown
Sophia Genetics SA
Balance Sheet Decomposition
Sophia Genetics SA
Current Assets | 90.1m |
Cash & Short-Term Investments | 68.5m |
Receivables | 10.7m |
Other Current Assets | 10.8m |
Non-Current Assets | 56.7m |
PP&E | 19m |
Intangibles | 30m |
Other Non-Current Assets | 7.7m |
Free Cash Flow Analysis
Sophia Genetics SA
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Sophia Genetics SA
Revenue
|
67.2m
USD
|
Cost of Revenue
|
-21.4m
USD
|
Gross Profit
|
45.7m
USD
|
Operating Expenses
|
-109.6m
USD
|
Operating Income
|
-63.8m
USD
|
Other Expenses
|
-2.3m
USD
|
Net Income
|
-66.2m
USD
|
SOPH Profitability Score
Profitability Due Diligence
Sophia Genetics SA's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
Score
Sophia Genetics SA's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
SOPH Solvency Score
Solvency Due Diligence
Sophia Genetics SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
Sophia Genetics SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SOPH Price Targets Summary
Sophia Genetics SA
According to Wall Street analysts, the average 1-year price target for SOPH is 7.82 USD with a low forecast of 5.05 USD and a high forecast of 11.55 USD.
Dividends
Current shareholder yield for SOPH is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one SOPH stock under the Base Case scenario is 4.58 USD.
Compared to the current market price of 3.75 USD, Sophia Genetics SA is Undervalued by 18%.